FDA Authorizes First Test for Patient At-Home Sample Collection

The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test home collection kit.

source https://www.pharmatutor.org/pharma-news/2020/fda-authorizes-first-test-for-patient-at-home-sample-collection